June 07, 2024
Boehringer Ingelheim’s survodutide shows significant improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
May 07, 2024
Boehringer Ingelheim receives Health Canada approval for SENVELGO™, the once-daily liquid oral solution for newly diagnosed diabetes in cats
April 16, 2024
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
March 13, 2024
Vancouver General Hospital pilots new plant-rich menu items for health of patients and planet
December 07, 2023
Boehringer Ingelheim Canada and community-based clinics join to revolutionize cardiovascular care in Ontario
November 21, 2023
Innovative digital therapeutics program shows a reduction in hospitalizations and costs for heart failure patients
October 30, 2023
Life forward - Boehringer Ingelheim unveils its evolved company brand
October 25, 2023
Breathing new life into patient care: Innovative partnership aims to transform interstitial lung disease support
October 11, 2023
Digital Clinical Support Tool Aims to Individualize Guidelines-Based Diabetes Care
September 27, 2023
University of Guelph’s Dr. Charlotte Winder named 2023 Metacam® 20 Bovine Welfare Award winner
August 01, 2023
First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas
Media contacts
Communications, Media & Public Relations
Director, Communications
Phone (905) 631-4713
Mobile (905) 599-2364
Communications, Media & Public Relations
Corporate Communications
Phone (905) 631-4531
Mobile (647) 637-8265
